Buy & Sell Shares With HL - The UK's #1 Platform For Private Investors. Risk Of Loss. Trade With Hargreaves Lansdown's Award Winning Share Dealing Platform. Risk Of Loss.
- How To Select Shares
Find 3 Easy Ways To Buy Shares
That Work. Download Our Guide
- Low Cost Share Dealing
Buy & Sell Shares Online From £5.95
To £11.95 Per Deal. Find Out More.
- Transferring Your Shares
Take Control Of Your Portfolio.
It's Easy To Transfer-Find Out More
- Share Tips & Research
View The Latest Share Tips &
Research From Our Research Team
- Share Research
Research On UK & US Shares From
Our Expert Shares Research Team
- Financial Advice
Get Flexible Financial Advice.
Nothing More, Nothing Less.
- How To Select Shares
Search results
$2.69 per share
- For the third quarter, Moderna stock analysts project adjusted losses of $2.69 per share and $1.24 billion in sales.
www.investors.com/news/technology/mrna-stock-buy-now/Is Moderna Stock A Sell After The Company Slashed Its R&D ...
People also ask
Why did Moderna lose a billion-dollar in 3rd quarter?
Why did Moderna beat sales expectations in the third quarter?
How did Moderna perform in the third quarter?
Why did Moderna lose $3bn?
Does Moderna need to sell shares?
How much does Moderna cost a year?
Nov 2, 2023 · The Boston-based biotech group, which was one of the pharmaceutical industry’s biggest winners from the coronavirus pandemic, reported a third-quarter loss of $3.6bn, or $9.53 a share, far...
Nov 2, 2023 · Moderna Inc. on Thursday reported a much wider-than-expected third quarter loss and reined in its full-year sales outlook as it resizes its pandemic-era manufacturing capacity and aims to...
Nov 3, 2022 · Third quarter 2022 revenues of $3.4 billion; GAAP net income of $1.0 billion and GAAP diluted EPS of $2.53. Revenue from advance purchase agreements for anticipated delivery in 2022 expected to be $18 to $19 billion, following delay of certain deliveries into 2023 due to short-term supply constraints
Nov 4, 2023 · Moderna reported a billion-dollar loss in the third quarter and began downsizing its manufacturing infrastructure to match lower levels of vaccine demand.
Nov 2, 2023 · Earnings (Loss) Per Share: Diluted loss per share was $9.53 for the third quarter of 2023, compared to diluted earnings per share of $2.53 for the third quarter of 2022.
Aug 1, 2024 · Guidance: For the second half of the year, Moderna expects a sales split of 40-50% in the third quarter, with the balance in the fourth quarter of 2024, subject to the timing of regulatory...
Nov 5, 2023 · Moderna recently reported third-quarter results. The stock is down about 84% from its peak in 2021. By the end of next year, Moderna could have a second product generating revenue.
